Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism TACC3 inhibitors(Transforming acidic coiled protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization A2a Pharmaceuticals, Inc.Startup |
Active Organization A2a Pharmaceuticals, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Preclinical | US | A2a Pharmaceuticals, Inc.Startup | 05 Apr 2022 |